CMS Open Payments · Program Year 2024
Elevate Oral Care
Elevate Oral Care reported $109,533.00 across General Payments, Research, and Ownership to 846 physicians and teaching hospitals across 862 transactions.
- $109.5K Below-median payer
- All-tracks total
- 862 Above-median volume
- Transactions
- 846 Above-median reach
- Recipients
- +$10.0K
- General Payments vs PY2023
Elevate Oral Care reported $109,533.00 across all CMS Open Payments tracks (General + Research + Ownership) to 846 physicians and teaching hospitals in Program Year 2024 - ranking #1160 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $47,081.06, averaging $129.47 per recipient.
How Elevate Oral Care's $109.5K all-tracks total breaks down
Elevate Oral Care's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
11/100
Transaction volume
F
16/100
Physician reach
F
16/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer elevate-oral-care Elevate Oral Care
$109.5K · #1160/1,925 · 0.0% industry · PY2024
- TOT $109.5K
- RANK #1160
- SHARE 0.0%
- TXN 862
- RCP 846
- CAT 2
- GEN $47.1K
- ΔGEN +$10.0K
- TOP1 28.5%
- PY 2024
Volume peers
Nearest volume peer: 60 Degrees Pharmaceuticals ($109.6K)
Elevate Oral Care sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Elevate Oral Care's CMS-reported General Payments increased by $10.0K (+27.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ELEVATE ORAL CAREPY2023: ELEVATE ORAL CAREPY2024: Elevate Oral Care. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $37,080.66
- PY2024
- $47,081.06
What the Data Shows for Elevate Oral Care
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Elevate Oral Care, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Compensation for Faculty or Speaker (Medical Education)" leads the 2-category general-payment breakdown below at $32.9K (69.8% of General Payments, 17 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Elevate Oral Care made 2 types of general payments. "Compensation for Faculty or Speaker (Medical Education)" is the largest category at $32.9K, 69.8% of General Payments.
How Elevate Oral Care divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Faculty or Speaker (Medical Education) | $32.9K | 17 | 69.8% |
| Food and Beverage | $14.2K | 829 | 30.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $30,926.43 (65.7%) of $47,081.06 in this company's General Payments records across 808 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Elevate Oral Care
The five named recipients with the highest reported General Payments from this company
- 1
Jeanette Maclean
$13,426.96 across 6 reported transactions
- 2
Jeremy Keeper
$10,882.47 across 5 reported transactions
- 3
Christina Carter
$3,000.00 across 2 reported transactions
- 4
Joseph R. Nemeth
$1,950.00 across 1 reported transactions
- 5
Douglas Young
$1,667.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Elevate Oral Care's spend rank (#1160 of 1,925, bottom 40% by spend) and concentration rank (#886 of 1,838, top 48% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Janssen Global Services, LLC : $1.8M total payments, HHI 1459
- Sequel Med Tech, LLC : $5.1K total payments, HHI 1455
- United Imaging Healthcare North America LLC : $51.7K total payments, HHI 1453
- Qapel Medical Inc : $256.6K total payments, HHI 1446
- CMS Imaging, Inc. : $44.5K total payments, HHI 1444
- Hu-Friedy Mfg. Co., LLC : $554.1K total payments, HHI 1438
- Elevate Oral Care (this company) : $47.1K total payments, HHI 1437
- Outset Medical Inc : $160.7K total payments, HHI 1433
- Total Joint Orthopedics, Inc. : $245.5K total payments, HHI 1433
- Great Lakes Medical Services, LLC : $5.8K total payments, HHI 1429
- Virtual Incision Corporation : $447.4K total payments, HHI 1423
- Aadi Bioscience, Inc. : $255.4K total payments, HHI 1423
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Elevate Oral Care's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Elevate Oral Care.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Elevate Oral Care.
Showing 6 of 1,924 companies with CMS-reported payment data.
Visionix USA, Inc
Sirona Dental Systems GmbH
Atos Medical Inc
Nucletron Operations B.V.
Substrate HD
Put this to use
Elevate Oral Care ranks #1160 of 1,925 by all-tracks total payments, led by "Compensation for Faculty or Speaker (Medical Education)".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Faculty or Speaker (Medical Education)" spend across every manufacturer, not just Elevate Oral Care. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.